Article: 3M's Aldara delayed for skin cancer.(3M Pharmaceuticals )(Brief Article)

3M Pharmaceuticals says that it has received an approvable letter from the US Food and Drug Administration in response to its supplemental New Drug Application for Aldara (imiquimod) cream for the treatment of superficial basal cell carcinoma.

The FDA noted no major deficiencies in the filing, but requested that 3M provide additional safety data before final approval can be granted. The ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!